Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 5, 2025 • 6:00 PM ET
As of January 5, 2025 • 6:00 PM ET
Date/Time | Source | News Release |
---|---|---|
11/19/2024 04:39 AM EST | US Earnings Reports | Expected earnings - Femasys Inc. |
11/12/2024 09:59 AM EST | SeekingAlpha | Femasys GAAP EPS of -$0.24, revenue of $554.91M |
11/12/2024 09:45 AM EST | Zacks | Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates |
11/07/2024 07:05 AM EST | Zacks | Zealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates |
11/06/2024 05:15 PM EST | Zacks | Arcutis Biotherapeutics, Inc. (ARQT) Reports Q3 Loss, Tops Revenue Estimates |
09/11/2024 08:47 AM EDT | SeekingAlpha | Femasys secures partnerships for commercialization of Femaseed and FemVue |
09/10/2024 10:41 AM EDT | Zacks | Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device |
09/07/2024 05:39 AM EDT | US Earnings Reports | Expected earnings - Femasys Inc. |
09/03/2024 09:43 AM EDT | Zacks | Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI |
08/09/2024 09:25 AM EDT | SeekingAlpha | Femasys reports Q2 results |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.